Celgene Corporation (NASDAQ:CELG) Gets FDA Fast Track Designation For Two Trials Celgene Corporation (NASDAQ:CELG) collaborations have been benefiting the company, and the U.S. Food and Drug Administration has given a green signal to two of its […]